Commentaries
Commentary: Cytokine inhibitors have a low prevalence of SARS-CoV-2 seroconversion
In a recent publication in Nature Communications1 a team from Friedrich-Alexander University in Germany described their findings from a cross-sectional
Tuesday, February 2, 2021
